Public Profile

Enzymotec Ltd.

Enzymotec Ltd., a leading biotechnology company headquartered in Israel, has been at the forefront of the nutritional and pharmaceutical industries since its founding in 1998. With a strong presence in North America, Europe, and Asia, Enzymotec focuses on developing innovative lipid-based products that cater to the needs of health-conscious consumers and medical professionals alike. The company is renowned for its unique offerings, including advanced lipid formulations and nutritional supplements that support cognitive health and overall wellness. Enzymotec's commitment to research and development has positioned it as a key player in the market, with notable achievements in product efficacy and safety. As a pioneer in the field, Enzymotec continues to drive advancements in nutritional science, making significant contributions to both consumer health and the broader industry landscape.

DitchCarbon Score

How does Enzymotec Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

45

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Enzymotec Ltd.'s score of 45 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Enzymotec Ltd.'s reported carbon emissions

Enzymotec Ltd., headquartered in Israel (IL), currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for Enzymotec Ltd. to establish clear climate commitments and reduction targets to align with global efforts in mitigating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Enzymotec Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Enzymotec Ltd. is in IL, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Enzymotec Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Grace Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Aker Biomarine

NO
Other business services (74)
Updated 3 days ago

Neptune Wellness Solutions Inc.

CA
Food products nec
Updated 3 days ago

Amarin Corporation plc

IE
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bioriginal

CA
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers